200 related articles for article (PubMed ID: 17290396)
21. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
[TBL] [Abstract][Full Text] [Related]
22. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
23. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
24. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
25. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.
Rácz A; Brass N; Heckel D; Pahl S; Remberger K; Meese E
Eur J Cancer; 1999 Apr; 35(4):641-6. PubMed ID: 10492640
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
Hellmann GM; Fields WR; Doolittle DJ
Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.
Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
BMC Cancer; 2009 Jul; 9():237. PubMed ID: 19607727
[TBL] [Abstract][Full Text] [Related]
30. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.
Koshikawa K; Osada H; Kozaki K; Konishi H; Masuda A; Tatematsu Y; Mitsudomi T; Nakao A; Takahashi T
Oncogene; 2002 Apr; 21(18):2822-8. PubMed ID: 11973641
[TBL] [Abstract][Full Text] [Related]
31. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
[TBL] [Abstract][Full Text] [Related]
32. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
[TBL] [Abstract][Full Text] [Related]
33. ADAM8 as a novel serological and histochemical marker for lung cancer.
Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
[TBL] [Abstract][Full Text] [Related]
34. Diversity of gene expression in adenocarcinoma of the lung.
Garber ME; Troyanskaya OG; Schluens K; Petersen S; Thaesler Z; Pacyna-Gengelbach M; van de Rijn M; Rosen GD; Perou CM; Whyte RI; Altman RB; Brown PO; Botstein D; Petersen I
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13784-9. PubMed ID: 11707590
[TBL] [Abstract][Full Text] [Related]
35. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
36. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification.
Angulo B; Suarez-Gauthier A; Lopez-Rios F; Medina PP; Conde E; Tang M; Soler G; Lopez-Encuentra A; Cigudosa JC; Sanchez-Cespedes M
J Pathol; 2008 Feb; 214(3):347-56. PubMed ID: 17992665
[TBL] [Abstract][Full Text] [Related]
37. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
38. True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs.
Brunelli M; Bria E; Nottegar A; Cingarlini S; Simionato F; Caliò A; Eccher A; Parolini C; Iannucci A; Gilioli E; Pedron S; Massari F; Tortora G; Borze I; Knuutila S; Gobbo S; Santo A; Tondulli L; Calabrò F; Martignoni G; Chilosi M
PLoS One; 2012; 7(12):e49689. PubMed ID: 23236352
[TBL] [Abstract][Full Text] [Related]
39. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
[TBL] [Abstract][Full Text] [Related]
40. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.
Shinomiya T; Mori T; Ariyama Y; Sakabe T; Fukuda Y; Murakami Y; Nakamura Y; Inazawa J
Genes Chromosomes Cancer; 1999 Apr; 24(4):337-44. PubMed ID: 10092132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
